Which Segment of the Healthcare Sector Will Be Most Affected by the Imposed Tariffs?
U.S. President Donald Trump has announced a 25% tariff on Indian imports, citing India’s “excessively high” tariffs among the highest…
IQVIA
Read More
Glenmark Pharma’s US Division Unveils Lacosamide Oral Solution for Seizure Management
Glenmark Pharmaceuticals Ltd announced on Monday, December 16, that its U.S. subsidiary has launched Lacosamide Oral Solution, 10 mg/mL, an…